UMIN-ICDS History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000061790
Receipt number	R000070458
Scientific Title	A Global Real World Platform Study Evaluating Teclistamab or Talquetamab as Primary Treatment for Patients with Relapsed or Refractory Multiple Myeloma who are Triple class Exposed in the Prior Lines of Therapy
Date of disclosure of the study information	2026/06/03
Last modified on	2026/06/03 18:56:24

---